FMP

FMP

Enter

WST - West Pharmaceut...

photo-url-https://images.financialmodelingprep.com/symbol/WST.png

West Pharmaceutical Services, Inc.

WST

NYSE

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

213.06 USD

-1.68 (-0.789%)

Historical Prices

From:

To:

212.87213213.5214214.5215215.3609:30 AM09:52 AM10:11 AM10:34 AM10:51 AM11:13 AM11:32 AM11:51 AM12:10 PM12:30 PM12:49 PM01:12 PM01:30 PM01:49 PM02:15 PM02:37 PM02:59 PM03:18 PM03:35 PM03:52 PM

About

ceo

Mr. Eric M. Green

sector

Healthcare

industry

Medical - Instruments & Supplies

exchange

NYSE

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection a...

CIK

0000105770

ISIN

US9553061055

CUSIP

955306105

Address

530 Herman O. West Drive

Phone

610 594 2900

Country

US

Employee

10,600

IPO Date

Mar 17, 1980

Financial Statement

0100M200M300M400M500M600M700M800M2024 Q12024 Q22024 Q32024 Q42025 Q1RevenueNet Income

Earnings

00.511.522.52023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q42025 Q1EPS Consensus

WST Financial Summary

CIK

0000105770

Exchange

NYSE

Industry

Medical - Instrument...

Sector

Healthcare

CUSIP

955306105

ISIN

US9553061055

Country

US

Price

213.06

Beta

1.14

Volume Avg.

1.21M

Market Cap

15.31B

Shares

-

52-Week

187.43-372.52

DCF

123.47

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

33.45

P/B

-

Website

https://www.westpharma.com

Upgrades and Downgrades

We are unable to load the data!

fmp-logo

Latest WST News

Alex Lavoie

Apr 23, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Earnings Previ...

West Pharmaceutical Services, Inc. (NYSE:WST) is a key player in the pharmaceutical industry, specializing in the design and manufacture of innovative solutions for injectable drug administration. The company is known for its strong presence in the biologics and contract manufacturing sectors. As WST prepares to release its first-quarter 2025 earnings, investors are keenly watching the anticipated figures. Wall Street estimates WST's earnings per share (EPS) to be $1.22, with projected revenue ...

Stuart Mooney

Feb 13, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Surpasses Earn...

West Pharmaceutical Services, Inc. (NYSE:WST) is a key player in the medical and dental supplies industry. The company specializes in the design and manufacture of innovative solutions for injectable drug administration. WST competes with other industry giants, focusing on providing high-quality products that meet the needs of healthcare providers and patients worldwide. On February 13, 2025, WST reported earnings per share (EPS) of $1.82, surpassing the estimated $1.71. This performance also e...

Rayan Ahmad

Feb 13, 2025

Casella Waste Systems, Inc. (NASDAQ:CWST) Financial Performa...

Casella Waste Systems, Inc. (NASDAQ:CWST) is a company that provides waste management services, including collection, transfer, disposal, and recycling. It operates primarily in the northeastern United States. The company competes with other waste management firms like Waste Connections, Inc., Clean Harbors, Inc., and Republic Services, Inc. These companies are also involved in similar waste management and environmental services. In analyzing Casella's financial performance, the Return on Inves...

Parth Sanghvi

Aug 6, 2024

Twist Bioscience Reports Robust Q3 Growth and Targets Higher...

Twist Bioscience Reports Robust Q3 Growth and Targets Higher Margins: Key Insights from the Earnings Call Twist Bioscience has recently shared its Q3 earnings report, highlighting impressive growth and ambitious plans for increasing profit margins. The company’s earnings call provided valuable details on its performance, strategic goals, and future outlook. Here’s a comprehensive overview of Twist Bioscience’s recent achievements and strategic focus. Highlights from Twist Bioscience’s Q3 E...

Seeking Alpha

Jul 25, 2024

West Pharmaceutical: Continued Destocking And A High Valuati...

West Pharmaceutical Q2'24 results missed expectations, with lower revenues and EPS missing guidance, impacted by destocking and poor sales in various segments. Management remains optimistic for the back half of the year, with capital investments to support growth, but cash flow concerns and high valuation pose risks. Despite the recent drop in WST share price, the company's high valuation and uncertain cash flow outlook make it unattractive for investment at this time.

Zacks Investment Research

Jul 25, 2024

West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 ...

West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.

Zacks Investment Research

Jul 25, 2024

West Pharmaceutical Services (WST) Q2 Earnings and Revenues ...

West Pharmaceutical Services (WST) came out with quarterly earnings of $1.52 per share, missing the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $2.11 per share a year ago.

Reuters

Jul 25, 2024

West Pharmaceutical lowers full-year sales, profit forecast ...

West Pharmaceutical Services cut its annual profit and sales forecast on Thursday, on lower demand for its medical equipment used in making injectable drugs as biotech customers worked through their existing inventories.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep